Skip to main content
. Author manuscript; available in PMC: 2014 Jan 15.
Published in final edited form as: Clin Cancer Res. 2012 Dec 3;19(2):347–356. doi: 10.1158/1078-0432.CCR-12-2046

Table 1.

Survival statistics from SCID-Raji xenograft study

Comparisons Estimate (difference
in days of survival)
P *95% CI
A: CD74-ILs vs. CD74 6.19 2.77–9.61
B: Herceptin-ILs vs. Herceptin −0.16 −5.17 to 4.85
A–B: Interaction between liposome and CD74 6.35 0.0405 0.28–12.41
C: CD74-IL-DEX vs. CD74-ILs 13.56 10.41–16.98
D: Herceptin-IL-DEX vs. Herceptin-ILs 0.13 −4.07 to 4.30
C–D: Interaction between CD74 and DEX (with liposome) 13.44 0.0002 8.03–18.84
CD74-IL-DEX vs. Herceptin-IL-DEX 29.4 0.0002 25.95–32.78